305.37 +0.27 (0.09%)
After hours: 4:24PM EDT
|Bid||288.60 x 900|
|Ask||441.00 x 1000|
|Day's Range||303.39 - 309.10|
|52 Week Range||229.84 - 309.19|
|PE Ratio (TTM)||23.95|
|Earnings Date||Aug 1, 2018|
|Forward Dividend & Yield||2.00 (0.65%)|
|1y Target Est||315.53|
In June, Humana executives have disposed of over $24 million in company stock, likely to take advantage of record-setting share prices for the company.
Humana Inc. executives appear to be selling stock while the Louisville-based company's share price remains near historic highs. Christopher Hunter, Humana's chief strategy officer, expected to sell 24,182 company shares for about $7.32 million on Wednesday, according to a U.S. Securities and Exchange Commission filing. The $7.32 million is based on a fair market value per share price of $302.69 based on prices on Tuesday, the filing states.
NEW YORK, June 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Humana ...
Humana Inc. will face an anti-kickback and False Claim Act lawsuit involving a deal it made with a division of international pharmaceutical giant Hoffman-La Roche Ltd. The U.S. District Court for the Northern District of Illinois tossed motions by Louisville-based Humana (NYSE: HUM) and Indianapolis-based Roche Diagnostics Corp. to dismiss a whistleblower case brought against the companies. The suit was brought by a now former Roche Diagnostics employee who, in part, alleges that Roche inappropriately dismissed debt Humana owed to Roche to keep Roche Diagnostic's diabetes testing products on Humana's formularies and to exclude competing products, according to copy of the court's decision. The civil complaint, which was filed in June 2014, alleges that this gave Roche inappropriate access to Humana's insurance plan participants.
Humana Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for HUM for clues.
Humana (HUM) enters into an agreement with Monida to provide better in-network access to Humana Medicare Advantage members.
Monida Healthcare Network, a Montana-based regional association of health care providers, and Humana Inc. , one of the nation’s leading health and well-being companies, have signed an agreement that expands in-network access for Humana Medicare members at Monida member hospitals and clinics in Montana.
Humana Inc. (HUM) and Transcend Insights, today announced that its technologies have been recognized by MedTech Breakthrough, an independent organization that honors the top companies, technologies and products in the global health and medical technology market. Together, Humana and Transcend Insights are focused on developing leading-edge technologies that deliver the right insights, to the right individuals, at the right time—a key initiative in support of Humana’s Bold Goal—helping its members become 20 percent healthier by 2020. The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including robotics, clinical administration, telehealth, patient engagement, electronic health records, mHealth, medical devices and medical data.
Investors pursuing a solid, dependable stock investment can often be led to Humana Inc (NYSE:HUM), a large-cap worth US$40.50B. Big corporations are much sought after by risk-averse investors who findRead More...
The Veterans of Foreign Wars of the U.S., Humana Inc. (HUM), Harvesters–The Community Food Network and After the Harvest announced they are “Uniting to Combat Hunger” through a collaborative campaign designed to raise awareness and fight food insecurity in the Greater Kansas City area. Food insecurity is a societal issue that affects 1 in 8 people in the United States.
Humana's shares price was $294.14 at the close of trading on Monday, according to Yahoo Finance historical data. Fleming, who is trained as a pharmacist, oversees all of Humana's clinical and pharmacy operations, and he reports to Humana (NYSE: HUM) president and CEO Bruce Broussard.
Moody's Investors Service, ("Moody's") assigned ratings to Gentiva Health Services, Inc., the borrower that will encompass the home health and hospice operations (Kindred at Home, or KAH) being carved out of Kindred Healthcare Inc. (B2 direction uncertain). Moody's assigned a Corporate Family Rating (CFR) of B2 and a Probability of Default Rating (PDR) of B2-PD.
Humana Inc. announced today that Brian A. Kane, Chief Financial Officer, will make a presentation to investors at the Goldman Sachs Healthcare Conference on Tuesday, June 12, 2018, at 10:00 a.m.
Community Health (CYH) recently closes the sale of 60-bed Byrd Regional Hospital and its associated assets besides the 85-bed Tennova Healthcare.
Humana AB (OM:HUM), a healthcare company based in Sweden, received a lot of attention from a substantial price increase on the OM over the last few months. As a stockRead More...
CarePlus Health Plans, a large Medicare Advantage provider in Florida, is now part of the exclusive agreement between its parent company, Humana Inc. , and the Veterans of Foreign Wars of the U.S.
Humana’s Complete Dental option is designed to provide immediate preventive care through cleanings and exams and, after standard wait periods, covers fillings and extractions as well as additional services such as root canals, crowns and dentures. Waiting periods may be waived if consumers have had 12 months of continuous prior dental coverage.
Today our own Jim Cramer discusses, in a two-part piece, how stocks that do well in a declining rate environment have come roaring back and the crash of oil will only accelerate the move. Read Part 1 of "Stocks That Do Well in a Declining Rate Environment Are Back" here and Part 2 here. In this daily bar chart of ANTM, below, we can see that the stock price of ANTM has been mostly trading between $220 to $240, with $230 seeing most of the action.
Anthem’s acquisition of palliative care provider Aspire Health is the latest effort by the health insurance industry to tap further into the management of serious advanced illness and end of life care, particularly for seniors in Medicare Advantage plans. Last month, Humana said it is buying a 40% stake in hospice provider Curo Health Services as part of a $1.4 billon acquisition by the insurer and private equity firms TPG Capital and Welsh, Carson, Anderson & Stowe.